CARDIAC RESEARCH INSTITUTE
0629.850.791 · rovalta.com · 26/09/2026
ACTIVE
CARDIAC RESEARCH INSTITUTE
Financial year 2025 · Closed on 31/12/2025
Net result313,8 k €+68,4 %over 1 year
Gross margin454,5 k €+64,9 %over 1 year
Equity206,2 k €-18,5 %over 1 year
Workforce0,4 ETP0,0 %over 1 year
Overview
Identity
Source · BCE/KBOCARDIAC RESEARCH INSTITUTE is a Private limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Aalst. It employs on average 0,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0629.850.791
- Incorporation
- 07/05/2015
- Legal form
- Private limited company
- Registered office
- Moorselbaan 164
9300 Aalst · FlandreSee on map - Contributed capital
- 142 405,65 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,4 ETP
Activities (NACE)
Joint committees (1)
- 200
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 10 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 454,5 k € | +64.9% | 275,7 k € | +95.3% | 141,1 k € | -18.2% | 172,5 k € | -19.7% | 214,9 k € |
| EBITDA | 424,5 k € | +72.1% | 246,7 k € | +127% | 108,7 k € | -26.7% | 148,3 k € | -22.2% | 190,6 k € |
| Operating result | 419,2 k € | +71.4% | 244,6 k € | +146% | 99,3 k € | -27.7% | 137,3 k € | -23.0% | 178,4 k € |
| Net result | 313,8 k € | +68.4% | 186,3 k € | +429% | 35,2 k € | -64.7% | 99,7 k € | -23.0% | 129,5 k € |
| Balance sheet | |||||||||
| Equity | 206,2 k € | -18.5% | 253,1 k € | -49.6% | 502 k € | +7.5% | 466,7 k € | +28.0% | 364,5 k € |
| Total assets | 1,9 M € | -11.1% | 2,1 M € | -6.5% | 2,2 M € | +8.0% | 2,1 M € | +48.2% | 1,4 M € |
| Cash | 115,2 k € | -88.1% | 967,4 k € | +93.8% | 499,1 k € | -66.3% | 1,5 M € | +63.8% | 902,8 k € |
| Debts | 1,7 M € | -10.0% | 1,8 M € | +34.5% | 1,4 M € | +37.3% | 997,6 k € | +41.4% | 705,3 k € |
| Other | |||||||||
| Workforce | 0,4 ETP | 0.0% | 0,4 ETP | 0.0% | 0,4 ETP | 0.0% | 0,4 ETP | 0.0% | 0,4 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20255 active · 19 ended
Active mandates
Active
Active
Active
Active
Ended mandates
Other companies at this address
Moorselbaan 164 9300 Aalst| Company | CBE no. |
|---|---|
| 1017.929.183 | |
Algemene Heelkunde AZORG● Active | 1017.519.607 |
| 1022.351.789 | |
Associatie Endocrinologie AZORG● Active | 1019.698.840 |
| 0760.768.525 | |
| 0769.516.143 | |
AZORG● Active | 1005.154.085 |
Azorg-ASZ● Active | 0686.624.891 |
| 0865.982.940 | |
CARDIO INVEST● Active | 1018.122.292 |
| 0470.425.452 | |
Centrale Inning AZORG● Active | 0775.987.330 |
| 0725.796.065 | |
| 0673.662.030 | |
Gastro-Enterologie AZORG● Active | 1023.116.012 |
Hartcentrum Aalst● Active | 1013.658.017 |
Levilo Health● Active | 1017.107.752 |
Maatschap Pool Cardio● Active | 0690.860.031 |
NEUROCHIRURGIE● Active | 0473.063.555 |
Niercentrum Azorg● Active | 1017.047.770 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/07/2026 | 15/07/2025 | 12/06/2024 | 25/07/2023 | 08/07/2022 | 20/07/2021 |
| General meeting | 15/06/2026 | 16/06/2025 | 03/06/2024 | 19/06/2023 | 20/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 15/06/2026 | 17/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/06/2025 | 15/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/06/2024 | 12/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 19/06/2023 | 25/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 20/06/2022 | 08/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/06/2021 | 20/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/06/2020 | 27/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 12/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/06/2018 | 08/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 22/06/2017 | 13/07/2017 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 19 ended
Active mandates
Active
Active
Active
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares25/06/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Capital / shares23/05/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Restructuring13/01/2025KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates30/12/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Restructuring14/11/2024RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates19/09/2022ONTSLAGEN - BENOEMINGEN
- Mandates22/07/2020ONTSLAGEN - BENOEMINGEN
- Mandates09/07/2018ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025313,8 k €↑
- 2024Annual accounts 2024186,3 k €↑
- 2023Annual accounts 202335,2 k €↓
- 2022Annual accounts 202299,7 k €↓
- 2021Annual accounts 2021129,5 k €↑
- 2018Annual accounts 201838,6 k €↑
- 2017Annual accounts 201713 k €
- 07/05/2015IncorporationPrivate limited company